General Information of the Compound
Compound ID |
CP0415089
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
5-(3,4-dichlorophenyl)-3-[4-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2-propylphenoxy]butyl]-5-methylimidazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C26H26Cl2F6N2O4
|
||||||||||||||||||
Molecular Weight |
615.398
|
||||||||||||||||||
Canonical SMILES |
CCCc1cc(ccc1OCCCCN1C(=O)NC(C)(C1=O)c1ccc(Cl)c(Cl)c1)C(O)(C(F)(F)F)C(F)(F)F
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C26H26Cl2F6N2O4/c1-3-6-15-13-17(24(39,25(29,30)31)26(32,33)34)8-10-20(15)40-12-5-4-11-36-21(37)23(2,35-22(36)38)16-7-9-18(27)19(28)14-16/h7-10,13-14,39H,3-6,11-12H2,1-2H3,(H,35,38)
Show/Hide
|
||||||||||||||||||
InChIKey |
PRQDVCHEULTZPU-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01555, Oxysterols receptor LXR-alpha
Protein ID: PT01887, Oxysterols receptor LXR-beta